Empowering Molecular Diagnostics: BIOTYPE Partners with Urteste S.A.

We’re proud to announce a new partnership with Urteste S.A., a pioneering company in early cancer detection through molecular diagnostics. This collaboration was facilitated by Dr. Achim Wehren from b2bio.

As part of the agreement, BIOTYPE will manufacture five batches of Urteste’s Panuri and Panuri Control kits. These will be used for analytical evaluation, validation testing, and a forthcoming clinical study.

This milestone marks a significant step in bringing innovative diagnostics closer to clinical application. We’re honored to support Urteste in this critical phase by delivering high-quality, scalable CDMO solutions.

Together, we’re advancing precision diagnostics and building impactful collaborations across the IVD landscape.